Literature DB >> 25580414

Comparison of compliance of adjuvant chemotherapy between laparoscopic and open surgery in patients with colon cancer.

Kan Ho Chun1, Byung Noe Bae1, Hoon An1, Hyeonseok Jeong1, Hyunjin Cho1, Geumhee Gwak1, Keun Ho Yang1, Ki Hwan Kim1, Hong Ju Kim1, Young Duk Kim1.   

Abstract

PURPOSE: Many studies have shown that the completion of adjuvant chemotherapy improves the survival rate. Recently, laparoscopic surgery has been used to treat patients with colon cancer. We analyzed the relationship between the completion of adjuvant chemotherapy and the operation method.
METHODS: We retrospectively analyzed the medical records of 147 patients diagnosed with colon cancer from January 1, 2009, to May 31, 2012. The numbers of patients who underwent laparoscopic and open surgery were 91 and 56, respectively. We analyzed the relationship between the operation method and various factors such as the completion rate of chemotherapy, the patient's age, gender, and physical activity, the postoperative hospital stay, the start time of chemotherapy, and the patient's body mass index (BMI), TNM stage, and type of health insurance.
RESULTS: In the laparoscopic surgery group, the postoperative hospital stay (13.5 ± 14.82 days vs. 19.6 ± 11.38 days, P = 0.001) and start time of chemotherapy (17.7 ± 17.48 days vs. 23.0 ± 15.00 days, P = 0.044) were shorter, but the percent complete of chemotherapy (71/91 [78.0%] vs. 38/56 [67.8%], P = 0.121), and survival rate (88/91 [96.7%], 47/56 [83.9%], P = 0.007) were higher than they were in the open surgery group. Patients who were elderly, had a low BMI, and a high American Society of Anesthesiologists score were less likely to complete adjuvant chemotherapy than other patients were.
CONCLUSION: Laparoscopic surgery shows a shorter postoperative hospital stay, a shorter start time of chemotherapy, and a higher survival rate. Laparoscopic surgery may be expected to increase compliance of chemotherapy and to improve survival rate.

Entities:  

Keywords:  Adjuvant chemotherapy; Colon neoplasms; Laparoscopy; Percent complete

Year:  2014        PMID: 25580414      PMCID: PMC4286774          DOI: 10.3393/ac.2014.30.6.274

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


  19 in total

1.  Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Duk Hyoung Lee; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

2.  Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.

Authors:  Hae Ran Yun; Hee Cheol Kim; Seong Hyeon Yun; Woo Yong Lee
Journal:  Hepatogastroenterology       Date:  2012 Nov-Dec

3.  Adjuvant chemotherapy for stage III colon cancer: does timing matter?

Authors:  Piotr M Czaykowski; Sharlene Gill; Hagen F Kennecke; Vallerie L Gordon; Donna Turner
Journal:  Dis Colon Rectum       Date:  2011-09       Impact factor: 4.585

4.  Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer.

Authors:  Chung-Yuan Hu; George L Delclos; Wenyaw Chan; Xianglin L Du
Journal:  Med Oncol       Date:  2010-08-17       Impact factor: 3.064

5.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.

Authors:  Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer
Journal:  Lancet Oncol       Date:  2008-12-13       Impact factor: 41.316

6.  Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.

Authors:  L G M van der Geest; J E A Portielje; M W J M Wouters; N I Weijl; B C Tanis; R A E M Tollenaar; H Struikmans; J W R Nortier
Journal:  Colorectal Dis       Date:  2013       Impact factor: 3.788

7.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

8.  Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.

Authors:  James Fleshman; Daniel J Sargent; Erin Green; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; Heidi Nelson
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

9.  Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer.

Authors:  Cathy J Bradley; Charles W Given; Bassam Dahman; Timothy L Fitzgerald
Journal:  Arch Intern Med       Date:  2008-03-10

10.  Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.

Authors:  A Gondos; F Bray; T Hakulinen; H Brenner
Journal:  Ann Oncol       Date:  2008-12-09       Impact factor: 32.976

View more
  3 in total

1.  Impact of type of surgery (laparoscopic versus open) on the time to initiation of adjuvant chemotherapy in operable rectal cancers.

Authors:  Snita Sinukumar; Shaesta Mehta; Vikas Ostwal; Sudhir Jatal; Avanish Saklani
Journal:  Indian J Gastroenterol       Date:  2015-08-07

2.  Effect of laparoscopic surgery on the initiation and completion of chemotherapy in patients with colon cancer.

Authors:  Min-Ki Kim; Won-Kyung Kang
Journal:  Ann Coloproctol       Date:  2014-12

3.  Comparison of Minimally Invasive Versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis.

Authors:  Jaewoo Kwon; Ki Byung Song; Seo Young Park; Dakyum Shin; Sarang Hong; Yejong Park; Woohyung Lee; Jae Hoon Lee; Dae Wook Hwang; Song Cheol Kim
Journal:  Cancers (Basel)       Date:  2020-04-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.